person

Yolanda C.

Country
Spain
Department
Nephrology department

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 5 partner sites.

Specializations

Renal and Metabolic Disorders

The investigator concentrates on chronic kidney disease and its complications, including management of nephrotic syndrome and associated metabolic abnormalities.

  • Proteinuria reduction strategies
  • Autoimmune glomerular disease therapies
  • Renal anemia treatment

Research integrates pediatric nephrology to address early‑onset renal pathology.

Hematologic Malignancies and Bone Marrow Failure

Focus includes aggressive blood cancers such as acute lymphoblastic leukemia and acute myeloid leukemia, as well as refractory lymphomas.

  • Targeted therapy for high‑risk leukemias
  • Stem cell transplant conditioning
  • Minimal residual disease monitoring

Efforts aim to improve survival outcomes for both adult and pediatric patients.

Pediatric Rare Genetic and Neurological Disorders

Investigation spans inherited conditions like Angelman syndrome, Krabbe disease, and developmental epilepsies.

  • Gene‑therapy delivery platforms
  • Neurodevelopmental outcome measures
  • Metabolic correction strategies

Collaboration with specialized pediatric units supports early intervention trials.

Immune‑Mediated Inflammatory Diseases

Key interests involve systemic autoimmunity such as systemic lupus erythematosus, juvenile idiopathic arthritis, and related vasculitides.

  • Biologic modulation of cytokine pathways
  • Biomarker identification for disease activity
  • Long‑term safety of immunosuppressants

Therapeutic development targets both adult and childhood disease phenotypes.

Pulmonary and Allergic Conditions

Research addresses chronic airway disorders including severe asthma and atopic dermatitis with overlapping allergic components.

  • Eosinophilic inflammation control
  • Topical and systemic therapy optimization
  • Quality‑of‑life endpoints in pediatric cohorts

Efforts emphasize personalized treatment pathways for refractory cases.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.